Does ADALIMUMAB Cause Mobility decreased? 8,829 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8,829 reports of Mobility decreased have been filed in association with ADALIMUMAB (YUSIMRY). This represents 1.8% of all adverse event reports for ADALIMUMAB.
8,829
Reports of Mobility decreased with ADALIMUMAB
1.8%
of all ADALIMUMAB reports
1,765
Deaths
3,730
Hospitalizations
How Dangerous Is Mobility decreased From ADALIMUMAB?
Of the 8,829 reports, 1,765 (20.0%) resulted in death, 3,730 (42.2%) required hospitalization, and 1,947 (22.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 8,829 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Mobility decreased?
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
PREDNISONE (3,699)
Which ADALIMUMAB Alternatives Have Lower Mobility decreased Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB